Riskpilot← Back to searchSign inGet full accessUpViser Oy
OYDissolvedY-tunnus 2123858-7C/O Mediq Suomi Oy Vuoritontunkuja 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20070 employeeswww.upviser.fi
Revenue 2021
EUR 8,2M
+34% vs 2020
EBITDA margin
2.0%
-64% vs 2020
Equity ratio
91.0%
Financial strength
Net profit 2021
EUR 6,9M
+695% vs 2020
| Revenue | EUR 8,2M | +34% |
| EBITDA | EUR 167K | -64% |
| Net profit | EUR 6,9M | +695% |
| Total assets | EUR 8,7M | +138% |
| Equity | EUR 7,9M | +283% |
| Employees | 0 | — |
Legal name
UpViser Oy
Y-tunnus number
2123858-7
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. kesäkuuta 2007
Share capital
EUR 26 358
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Yhtiön toimialana on harjoittaa kirurgian erikoisalojen tarvitsemien erityistuotteiden maahantuontia, myyntiä ja markkinointia ja niihin liittyvien palvelujen tarjontaa. Yhtiö voi omistaa, hallita, vuokrata ja tehdä kauppaa aineettomilla oikeuksilla, osakkeilla ja kiinteistöillä sekä harjoittaa sijoitustoimintaa.
Address
C/O Mediq Suomi Oy Vuoritontunkuja 6
Phone
+3580201121500
Email
asiakaspalvelu@mediq.com
Website
www.upviser.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 6 288 | 6 106 | 8 187 |
| Staff expenses | −1 333 | −1 348 | −1 551 |
| EBITDA | 599 | 468 | 167 |
| Depreciation & amort. | −11 | −10 | −8 |
| EBIT | 588 | 459 | 159 |
| Net financials | 180 | 499 | 42 |
| Profit before tax | 768 | 958 | 5 580 |
| Tax | 122 | 93 | −1 297 |
| Net profit | 646 | 865 | 6 876 |
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Total assets | 3 170 | 3 669 | 8 720 |
| Equity | 1 648 | 2 074 | 7 932 |
| Long-term debt | 269 | 331 | 10 |
| Short-term debt | 1 253 | 1 264 | 778 |
| Total debt | 1 522 | 1 595 | 788 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20192021
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20192021
Return on equity
86.7%
This company
18.4%
Market median
+371% vs market
20192021
Net profit margin
84.0%
This company
8.1%
Market median
+937% vs market
20192021
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20192021
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20192021
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
NJ Chief Executive Officer | Chief Executive Officer | 2020 |
| Audit | 2013 | |
JT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2018 |
| Former (2) | ||
MY Chief Executive Officer | Chief Executive Officer | 2018 – 2020 |
AP Deputy auditor | Deputy auditor | 2013 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairperson | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UpViser Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niko Jyri Suominen | Chief Executive Officer | 0 companies |
| Mika Yrjänä Suominen | Chief Executive Officer | 0 companies |
| Marko Eero Sakari Tiilikainen | Audit | 0 companies |
| Jorma Tapani Tiili | Deputy Chief Executive Officer | 0 companies |
| Anssi Petteri Tikkanen | Deputy auditor | 0 companies |
| Jan Henning Albrechtsen | Board of Directors | 0 companies |
| Christian Kanstrup | Chairperson | 0 companies |
| Ilari Juhana Vaalavirta | Board of Directors | 0 companies |